Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · IEX Real-Time Price · USD
39.15
-0.30 (-0.76%)
At close: Jul 2, 2024, 4:00 PM
38.69
-0.46 (-1.17%)
After-hours: Jul 2, 2024, 7:30 PM EDT
Tandem Diabetes Care Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for TNDM stock have an average target of 49.54, with a low estimate of 24 and a high estimate of 75. The average target predicts an increase of 26.54% from the current stock price of 39.15.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TNDM stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 6 | 5 |
| Buy | 3 | 3 | 3 | 5 | 5 | 6 |
| Hold | 7 | 7 | 7 | 3 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 14 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $47 → $58 | Buy | Maintains | $47 → $58 | +48.15% | Jun 10, 2024 |
| Redburn Atlantic | Redburn Atlantic | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +53.26% | May 30, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $60 → $75 | Strong Buy | Maintains | $60 → $75 | +91.57% | May 22, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $40 → $57 | Hold → Strong Buy | Upgrades | $40 → $57 | +45.59% | May 22, 2024 |
| Stifel | Stifel | Strong Buy Maintains $45 → $55 | Strong Buy | Maintains | $45 → $55 | +40.49% | May 22, 2024 |
Financial Forecast
Revenue This Year
887.24M
from 747.72M
Increased by 18.66%
Revenue Next Year
989.79M
from 887.24M
Increased by 11.56%
EPS This Year
-1.69
from -3.43
EPS Next Year
-1.13
from -1.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 927.5M | 1.1B | 1.3B | 1.3B | 1.4B |
| Avg | 887.2M | 989.8M | 1.1B | 1.2B | 1.3B |
| Low | 848.9M | 919.2M | 988.8M | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 24.0% | 27.8% | 32.8% | 14.2% | 16.1% |
| Avg | 18.7% | 11.6% | 10.6% | 7.1% | 8.7% |
| Low | 13.5% | 3.6% | -0.1% | -0.9% | -0.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.55 | -0.80 | -0.48 | -0.86 | -0.47 |
| Avg | -1.69 | -1.13 | -0.73 | -0.84 | -0.46 |
| Low | -1.78 | -1.36 | -0.97 | -0.80 | -0.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.